CHF
MCID: CNG034
MIFTS: 72

Congestive Heart Failure (CHF) malady

Categories: Cardiovascular diseases

Aliases & Classifications for Congestive Heart Failure

Aliases & Descriptions for Congestive Heart Failure:

Name: Congestive Heart Failure 38 12 14 69
Congestive Heart Disease 12 29
Heart Failure 42 69
Cardiac Failure Congestive 12
Heart Failure Congestive 52
Weak Heart 12
Chf 12

Classifications:



Summaries for Congestive Heart Failure

Disease Ontology : 12 A heart disease that is characterized by any structural or functional cardiac disorder that impairs the ability of the heart to fill with or pump a sufficient amount of blood throughout the body.

MalaCards based summary : Congestive Heart Failure, also known as congestive heart disease, is related to pericarditis and myocardial infarction, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Congestive Heart Failure is ACE (Angiotensin I Converting Enzyme), and among its related pathways/superpathways are Peptide ligand-binding receptors and Vascular smooth muscle contraction. The drugs Ethanol and Heparin have been mentioned in the context of this disorder. Affiliated tissues include Adipose and Lateral Plate Mesoderm, and related phenotypes are cardiovascular system and homeostasis/metabolism

Related Diseases for Congestive Heart Failure

Diseases related to Congestive Heart Failure via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 321)
id Related Disease Score Top Affiliating Genes
1 pericarditis 29.6 ACE EDN1 KNG1 REN
2 myocardial infarction 29.5 ACE ADM ADRB1 ADRB2 AGTR1 EDN1
3 heart disease 11.4
4 rheumatic heart disease 11.4
5 mental retardation, x-linked, syndromic 32 11.2
6 pulmonary edema 11.2
7 peripartum cardiomyopathy 11.1
8 congenital hepatic fibrosis 11.1
9 ventricular septal defect 2 11.0
10 pleural disease 11.0
11 ventricular septal defect 1 11.0
12 ventricular septal defect 3 11.0
13 crimean-congo hemorrhagic fever 10.9
14 cardiomyopathy, dilated, 1g 10.8
15 cardiomyopathy, dilated, 1p 10.8
16 cardiomyopathy, dilated, 1m 10.8
17 cardiomyopathy, dilated, 1bb 10.8
18 cardiomyopathy, dilated, 1j 10.8
19 atrial fibrillation, familial, 13 10.8
20 cardiomyopathy, dilated, 1i 10.8
21 left ventricular noncompaction 10 10.8
22 carcinoid syndrome 10.8
23 cardiomyopathy, dilated, 2a 10.8
24 left ventricular noncompaction 8 10.8
25 cardiomyopathy, dilated, 2b 10.8
26 cardiomyopathy, dilated, 1ii 10.8
27 cardiomyopathy, dilated, 1ff 10.8
28 cor triatriatum 10.8
29 atrial fibrillation, familial, 6 10.8
30 cardiomyopathy, familial hypertrophic 10.8
31 atrial fibrillation, familial, 14 10.8
32 atrial fibrillation, familial, 4 10.8
33 cardiomyopathy, dilated, 1nn 10.8
34 long qt syndrome-10 10.8
35 cardiomyopathy, dilated, 3b 10.8
36 cardiomyopathy, dilated, 1z 10.8
37 brugada syndrome 7 10.8
38 cardiomyopathy, dilated, 1cc 10.8
39 cardiomyopathy, dilated, 1e 10.8
40 atrial fibrillation, familial, 7 10.8
41 malouf syndrome 10.8
42 atrial fibrillation, familial, 11 10.8
43 atrial fibrillation, familial, 10 10.8
44 cardiomyopathy, dilated, 1x 10.8
45 cardiomyopathy, dilated, 1o 10.8
46 dyserythropoietic anemia, congenital, type ia 10.8
47 myl4-related familial atrial fibrillation 10.8
48 cardiomyopathy, dilated, 1a 10.8
49 cardiomyopathy, dilated, 1gg 10.8
50 cardiomyopathy, dilated, 1kk 10.8

Graphical network of the top 20 diseases related to Congestive Heart Failure:



Diseases related to Congestive Heart Failure

Symptoms & Phenotypes for Congestive Heart Failure

UMLS symptoms related to Congestive Heart Failure:


angina pectoris, chest pain, edema, tremor, equilibration disorder, syncope

MGI Mouse Phenotypes related to Congestive Heart Failure:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.25 NPR1 NR3C2 PIK3C2A REN ACE ADM
2 homeostasis/metabolism MP:0005376 10.25 ACE ADM ADRB1 ADRB2 AGTR1 AQP2
3 growth/size/body region MP:0005378 10.18 ACE ADRB1 ADRB2 AGTR1 AQP2 EDN1
4 hematopoietic system MP:0005397 10.18 AQP2 ACE ADM ADRB2 AGTR1 AMPD1
5 immune system MP:0005387 10 EPO MME NPR1 PIK3C2A REN ACE
6 mortality/aging MP:0010768 10 ACE ADM ADRB1 AGTR1 AMPD1 AQP2
7 muscle MP:0005369 9.65 ADM ADRB1 ADRB2 EDN1 EDNRA EPO
8 renal/urinary system MP:0005367 9.32 ACE ADM AGTR1 AQP2 EDN1 EDNRA

Drugs & Therapeutics for Congestive Heart Failure

Drugs for Congestive Heart Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 965)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 64-17-5 702
2
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
3
Norepinephrine Approved Phase 4,Phase 3,Phase 1 51-41-2 439260
4
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
5
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 10102-43-9 145068
6
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2 23214-92-8 31703
7
Pravastatin Approved Phase 4,Phase 3 81093-37-0 54687
8
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
9
Simvastatin Approved Phase 4,Phase 3,Early Phase 1 79902-63-9 54454
10
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
11
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
12
Testosterone Approved, Investigational Phase 4,Phase 2 58-22-0 6013
13
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Early Phase 1 50-78-2 2244
14
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757 53477783
15
Verapamil Approved Phase 4,Phase 3 52-53-9 2520
16
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 33069-62-4 36314
17
Digoxin Approved Phase 4,Phase 2,Phase 3,Phase 1 20830-75-5 30322 2724385
18
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 50-18-0, 6055-19-2 2907
19
Iron Approved Phase 4,Phase 2,Phase 3,Phase 1 7439-89-6 23925
20
Furosemide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 54-31-9 3440
21
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
22
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1 657-24-9 14219 4091
23
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 75847-73-3 5362032 40466924
24
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
25
Enalaprilat Approved Phase 4,Phase 3,Phase 2,Phase 1 76420-72-9 6917719
26
Spironolactone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1952-01-7, 52-01-7 5833
27
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137862-53-4 60846
28
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-93-5 3639
29
Candesartan Approved Phase 4,Phase 3,Phase 2,Phase 1 139481-59-7 2541
30
Telmisartan Approved, Investigational Phase 4,Phase 2,Phase 3 144701-48-4 65999
31
Amlodipine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 88150-42-9 2162
32
Carvedilol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 72956-09-3 2585
33
Bisoprolol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 66722-44-9 2405
34
Eplerenone Approved Phase 4,Phase 3,Phase 2,Phase 1 107724-20-9 150310 443872
35
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2 37350-58-6, 51384-51-1 4171
36
Diltiazem Approved Phase 4,Phase 3 42399-41-7 39186
37
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2 1951-25-3 2157
38
Nitroglycerin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 55-63-0 4510
39
Nebivolol Approved, Investigational Phase 4,Phase 2,Phase 3 152520-56-4, 99200-09-6, 118457-14-0 71301
40
Warfarin Approved Phase 4,Phase 3,Phase 2 81-81-2 6691 54678486
41
Deferoxamine Approved, Investigational Phase 4 70-51-9 2973
42
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
43
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
44
Ticlopidine Approved Phase 4,Phase 2,Phase 3 55142-85-3 5472
45
Terbutaline Approved Phase 4 23031-25-6 5403
46
Infliximab Approved Phase 4 170277-31-3
47
Amiloride Approved Phase 4,Phase 2,Phase 3,Phase 1 2016-88-8, 2609-46-3 16231
48
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 58-61-7 60961
49
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
50
Dobutamine Approved Phase 4,Phase 2,Phase 3,Phase 1 34368-04-2 36811

Interventional clinical trials:

(show top 50) (show all 4802)
id Name Status NCT ID Phase
1 DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure Unknown status NCT02312427 Phase 4
2 Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure Unknown status NCT00793338 Phase 4
3 Add-on Aliskiren Treatment in Patients With Chronic Congestive Heart Failure Unknown status NCT01040494 Phase 4
4 A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients Unknown status NCT00690521 Phase 4
5 THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure Unknown status NCT01640639 Phase 4
6 Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure Unknown status NCT00988806 Phase 4
7 PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing Unknown status NCT00409916 Phase 4
8 A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL) Unknown status NCT00247000 Phase 4
9 Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial Unknown status NCT00937092 Phase 4
10 Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients Unknown status NCT01930734 Phase 4
11 Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction Unknown status NCT02046044 Phase 4
12 Medtronic South Asian Systolic Heart Failure Registry Unknown status NCT01434615 Phase 4
13 Quadripolar Leads for the Management of Heart Failure Patients in the Middle East Unknown status NCT02195843 Phase 4
14 Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure Unknown status NCT00527059 Phase 4
15 Platelet Inhibition in Patients With Systolic Heart Failure Unknown status NCT01765400 Phase 4
16 Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects Unknown status NCT01813201 Phase 4
17 Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. Unknown status NCT02087332 Phase 4
18 Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy Unknown status NCT00348530 Phase 4
19 Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism Unknown status NCT02316743 Phase 4
20 Effects of Atrial Rate-adaptive Pacing on Exercise Capacity in Patients With Chronic Heart Failure Complicated by Chronotropic Incompetence Unknown status NCT01016431 Phase 4
21 Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure Unknown status NCT01156207 Phase 4
22 Therapy With Verapamil or Carvedilol in Chronic Heart Failure Unknown status NCT00374465 Phase 4
23 A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure Unknown status NCT02135835 Phase 4
24 Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat Unknown status NCT01612260 Phase 4
25 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4
26 Danish ICD Study in Patients With Dilated Cardiomyopathy Unknown status NCT00542945 Phase 4
27 CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up Unknown status NCT00318357 Phase 4
28 Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication Unknown status NCT01415024 Phase 4
29 Treatment of Cheyne Stocks Respiration With Adaptive Servo Ventilation and Bilevel Ventilators in Patients With Chronic Heart Failure Unknown status NCT00725595 Phase 4
30 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4
31 LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure Unknown status NCT00668408 Phase 4
32 Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy Unknown status NCT01293903 Phase 4
33 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4
34 The Angiotensin Converting Enzyme (ACE) Inhibitor SwitchBack Study Unknown status NCT01162980 Phase 4
35 Ability of Metoprolol to Alter the Exercise Induced Elevation of Catecholamines Unknown status NCT00885651 Phase 4
36 Latin America Cardiac Resynchronization Therapy Study Unknown status NCT01238874 Phase 4
37 Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy Unknown status NCT02166060 Phase 4
38 Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity Unknown status NCT00326690 Phase 4
39 Mode Evaluation in Sick Sinus Syndrome Trial (MODEST) Unknown status NCT00161551 Phase 4
40 Ventricular Pacing Site Selection (V-PASS) Unknown status NCT00292383 Phase 4
41 Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD Placement Unknown status NCT01717209 Phase 4
42 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
43 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4
44 Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function Unknown status NCT00418119 Phase 4
45 Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant Unknown status NCT00552851 Phase 4
46 Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism Unknown status NCT02132689 Phase 4
47 Effect of Conditioning on Myocardial Damage in STEMI Unknown status NCT02158468 Phase 4
48 Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block Unknown status NCT00709774 Phase 4
49 Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery Unknown status NCT01524315 Phase 4
50 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4

Search NIH Clinical Center for Congestive Heart Failure

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Congestive Heart Failure cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Congestive Heart Failure:
ACP-01, autologous angiogenic precursor cells for cardiac diseases
Adipose-derived stem cells for treatment of congestive heart failure
BMAC
Bone marrow-derived adult mononuclear cells for heart diseases
Cardiac progenitor cells for single-ventricle anomalies
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
C-Cure
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
CD34+ stem cells for treatment of congestive heart failure
Enriched bone marrow-derived progenitor cells for heart diseases
ERCs, endometrial regenerative cells for congestive heart failure
Human cardiac-derived stem cell for the treatment of congestive heart failure
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
MyoCell
Peripheral or bone marrow-derived stem cells for chronic heart failure
Embryonic/Adult Cultured Cells Related to Congestive Heart Failure:
Angiogenic cell precursors
Adipose-derived mesenchymal stem cells (family)
Bone Marrow Aspirate Concentrated Nucleated Cells (BMAC) PMIDs: 15995108 23788089 18351022
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Cardiac stem cells PMIDs: 18754813 17502484 14530411
Cardiac progenitor cells PMIDs: 18754813 17502484 14530411
Cardiosphere-derived cells PMIDs: 22336189
Cardiomyocyte-like cells PMIDs: 23583247 18835562
Bone marrow-derived CD133+ cells PMIDs: 17320570
Bone marrow-derived hematopoietic stem cells (family) PMIDs: 22163120
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Endometrial regenerative cells PMIDs: 18005405 23510656 20398245 19232091
Human cardiac stem cells PMIDs: 17502484 19038683 17150190
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mononuclear cells PMIDs: 20668107 21596713 19761394 22834565

Cochrane evidence based reviews: heart failure

Genetic Tests for Congestive Heart Failure

Genetic tests related to Congestive Heart Failure:

id Genetic test Affiliating Genes
1 Congestive Heart Failure 29

Anatomical Context for Congestive Heart Failure

MalaCards organs/tissues related to Congestive Heart Failure:

39
Heart, Bone, Brain, Endothelial, Kidney, Lung, Testes
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Congestive Heart Failure:
id Tissue Anatomical CompartmentCell Relevance
1 Adipose Subcutaneous White Adipose Mesenchymal Stem Cells Potential therapeutic candidate
2 Lateral Plate Mesoderm Splanchnic Mesoderm Pericytes Potential therapeutic candidate
3 Adipose Subcutaneous White Adipose Stromal Cells Potential therapeutic candidate

Publications for Congestive Heart Failure

Articles related to Congestive Heart Failure:

(show top 50) (show all 1359)
id Title Authors Year
1
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure. ( 27993963 )
2017
2
Veterans' Voice Through the Lens of Their Medical Records: What It Reveals About Congestive Heart Failure Readmissions. ( 27902575 )
2017
3
Congestive heart failure: More common as well as an important cardiovascular outcome - reply. ( 28069608 )
2017
4
Use of Biomarkers to Predict Readmission for Congestive Heart Failure. ( 27939586 )
2017
5
High-Intensity Training Improves Global and Segmental Strains in Severe Congestive Heart Failure. ( 28069473 )
2017
6
Investigation of the link between fluid shift and airway collapsibility as a mechanism for obstructive sleep apnea in congestive heart failure. ( 28057850 )
2017
7
Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. ( 28055049 )
2017
8
The NF-kB regulates the SHP-1 expression in monocytes in congestive heart failure. ( 27814644 )
2017
9
Prognostic Importance of Atrial Fibrillation Timing and Pattern in Adults with Congestive Heart Failure: a Systematic Review and Meta-Analysis. ( 27565044 )
2016
10
Congestive heart failure in children with pneumonia and respiratory failure. ( 27589216 )
2016
11
Continuous infusion or bolus injection of loop diuretics for congestive heart failure? ( 27145033 )
2016
12
Core Measures for Congestive Heart Failure in a Tertiary Care Setting in Pakistan. ( 27630801 )
2016
13
Development of a clinical prediction score for congestive heart failure diagnosis in the emergency care setting: The Brest score. ( 27599400 )
2016
14
Meaning in life and violations of beliefs and goals: reciprocal relations among individuals with congestive heart failure. ( 27824491 )
2016
15
Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. ( 27644192 )
2016
16
Pursuing early catheter ablation to treat atrial fibrillation in the congestive heart failure population: significance of the AATAC trial results. ( 27619629 )
2016
17
B-type Natriuretic Peptide Assay in Differentiating Congestive Heart Failure from Lung Disease in Patients Presenting with Dyspnea. ( 27612893 )
2016
18
Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601562 )
2016
19
Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction. ( 27127397 )
2016
20
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. ( 27029350 )
2016
21
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure. ( 27019042 )
2016
22
Congestive heart failure: more common as well as an important cardiovascular outcome. ( 28025215 )
2016
23
Association between polymorphisms of the HSPB7 gene and Cheyne-Stokes respiration with central sleep apnea in patients with dilated cardiomyopathy and congestive heart failure. ( 27441470 )
2016
24
The Performance of Short-Term Heart Rate Variability in the Detection of Congestive Heart Failure. ( 27891509 )
2016
25
Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure. ( 27898735 )
2016
26
A Novel and Effective Method for Congestive Heart Failure Detection and Quantification Using Dynamic Heart Rate Variability Measurement. ( 27835634 )
2016
27
Systolic and Diastolic Function in Congestive Heart Failure Pediatric Patients. ( 27141569 )
2016
28
Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure. ( 27399111 )
2016
29
Letter from Liu and Yang Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601563 )
2016
30
Complexity in congestive heart failure: A time-frequency approach. ( 27036183 )
2016
31
Trends in hospitalization for congestive heart failure, 1996-2009. ( 27862089 )
2016
32
Weight Management Belief is the Leading Influential Factor of Weight Monitoring Compliance in Congestive Heart Failure Patients. ( 27899858 )
2016
33
Reduction of psycho-spiritual distress of an elderly with advanced congestive heart failure by life review interview in a palliative care day center. ( 27621805 )
2016
34
Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure? ( 27598860 )
2016
35
A case report of primary cardiac myxofibrosarcoma presenting with severe congestive heart failure. ( 27387491 )
2016
36
Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601564 )
2016
37
Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease. ( 26831162 )
2016
38
Natriuretic peptide hormones in congestive heart failure: challenges, clinical interpretation and review of studies. ( 27594357 )
2016
39
Evaluation of the efficacy of a nurse practitioner-led home-based congestive heart failure clinical pathway. ( 27064361 )
2016
40
Can Bedside Ultrasound Inferior Vena Cava Measurements Accurately Diagnose Congestive Heart Failure in the Emergency Department? A Clin-IQ. ( 27857946 )
2016
41
Congestive heart failure detection using random forest classifier. ( 27208521 )
2016
42
Inspiratory muscle training in stroke patients with congestive heart failure: A CONSORT-compliant prospective randomized single-blind controlled trial. ( 27631248 )
2016
43
Evolution of a 90-Day Model of Care for Bundled Episodic Payments for Congestive Heart Failure in Home Care. ( 27158856 )
2016
44
An autopsy case of hyperthyroid cardiomyopathy manifesting lethal congestive heart failure. ( 28008703 )
2016
45
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. ( 28012165 )
2016
46
PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients. ( 27161690 )
2016
47
Congestive Heart Failure and Noncardiac Operations: Risk of Serious Morbidity, Readmission, Reoperation, and Mortality. ( 27106641 )
2016
48
Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601561 )
2016
49
Trapped lung secondary to cardiomegaly in a 78 year-old male with congestive heart failure. ( 27054087 )
2016
50
Congestive Heart Failure and Central Sleep Apnea. ( 26972039 )
2016